Long non-coding RNAs and cervical cancer

Cervical cancer is determined as the second highest number of deaths factor in female cancers. Here is a need to find new biomarkers for detection and preliminary prognosis, metastasis. To find new treatment to enhance the survival of cervical cancer patients, pivotal actions are necessitated to be...

Full description

Saved in:
Bibliographic Details
Published inExperimental and molecular pathology Vol. 106; pp. 7 - 16
Main Authors Aalijahan, Hamid, Ghorbian, Saeid
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.02.2019
Subjects
Biomarker
Cervical cancer
HOTAIR
LncRNAs
Prognosis
HOTAIR
Biomarker
Prognosis
Cervical cancer
LncRNAs
Online AccessGet full text

Cover

More Information
Summary:Cervical cancer is determined as the second highest number of deaths factor in female cancers. Here is a need to find new biomarkers for detection and preliminary prognosis, metastasis. To find new treatment to enhance the survival of cervical cancer patients, pivotal actions are necessitated to be implemented. Long non-coding RNAs (lncRNAs) appear to be the crucial modulators in various processes and critically influence the oncogenesis. The commencement and general review actions of the following lncRNAs HOTAIR, H19, XIST, CCHE1, EBIC, MALAT1, ANRIL, LET, NEAT1, BLACAT1, UFC1, SNHG16 and SNHG20 are focused in this review article. Roles of the lncRNAs in cervical cancer in terms of prognosis and tumor progression, invasion and metastasis, apoptosis, and radio-resistance are pointed out. In this review the utilization of lncRNAs as biomarkers in cervical cancer prognosis for metastasis is discussed. An overview of this review will be useful for selection of biomarkers in diagnosis, prognosis, and targeted therapy of cervical cancer in the future.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0014-4800
1096-0945
1096-0945
DOI:10.1016/j.yexmp.2018.11.010